Dealmakers Update - January 2010
Sponsored this month by:
BioNetwork East
At BioNetwork East taking place March 15-17 in Miami Beach, FL you’ll meet global biotech and pharmaceutical companies ready to partner.
Register online at www.BioNetworkEast.com or call 646-200-7530.
Mention your code 10840.004XZ884NL to get 25% off.
 |
- Editor's corner
- In the news
- Scorecard update
- Partnering roundup
- Best practice articles
-
Forthcoming events
- Latest business reports
- On the move - latest updates
|
Editor's corner
Happy new year to all our dealmaker readers!
Hopefully, 2010 will be a year of growth for biopharma, with commercialization of promising new drugs via partnering and M&A. For all the challenges of the past twelve months, we must never lose focus on the main challenge - improving peoples lives through health. The new year will provide many challenges but also huge opportunities.
Now is the time to start planning your partnering event attendance for 2010 - the following are our suggested must attend events: Biobusiness 2010, Biopartnering North America, Drug Delivery Partnerships, BioEurope Spring, plus the new combined BioWindhover/Pharmaceutical Strategic Outlook 2010. In addition, the new and innovative PharmaPartneringLive 2010 seeks to provide the first completely virtual partnering event in May 2010.
NEW FOR 2010 Due to popular demand, we have added a new interim newsletter - Dealmakers Round-Up. This new newsletter is delivered to all our recipients towards the end of each month, providing up to the minute access to our industry round-up and in the news sections cthat ontinue to provide insight and are updated daily online, providing you with the latest trends from the world's most respected publishers and deal news direct from biopharma companies as they are announced.
You can also follow these updates via our LinkedIn and Twitter pages - sign up here.
Our latest report: Drug Delivery Partnering Agreements in Pharma and Biotech is now available, providing insight and access to hundreds of partnering contract documents.
Our publishing arm has been busy introducing new reports - here are just a few of the titles to facilitate partnering in 2010:
All for now!
-- Steve Poile --
In the news
The following are just some of the deals involving bigpharma announced in the last few weeks:
Deals of note so far in January 2010:
- Sanofi-Aventis commences tender offer for Chattem
- AnaptysBio in agreement with Roche to develop novel antibodies
- KaloBios partners with Sanofi Pasteur on novel prevention and treatment for Pseudomonas aeruginosa
- GlaxoSmithKline in Traficet-EN licensing deal with ChemoCentryx
- BioMimetic strengthens agreement with Novartis Vaccines & Diagnostics for exclusive supply of rhPDGF-BB
- Clinical candidate from PKB/AKT collaboration with Astex Therapeutics selected by AstraZeneca
- AstraZeneca in deal with Teva for Nexium
- Pfizer and Debiopharm collaborate to co-develop Tremelimumab in advanced melanoma
Keep posted on the latest deals and alliances with CurrentPartnering's In the news feature.
Signup for our updates via LinkedIn and Twitter.
Partnering roundup
Just some of the articles picked up by Roundup during early January:
- Big Firms Will Fight The Patent Cliff
- Icahn Considering Proxy Battle at Genzyme
- Teva’s Yanai Forecasts $31 Billion in Revenue by 2015
- Merck And Pfizer Plan 900 Job Cuts
- FDA Drug Approvals in 2009 - Up (a Little) from 2008
- Top 10 outsourcing trends for 2010
- Biogen Idec Launches Search for New CEO
- Lilly Taps Contractors to Revive Pipeline
Follow Roundup online here
Signup for our updates via LinkedIn and Twitter.
Scorecard update
Updated today - January 12, 2010
Our Scorecard Index provides a simple overview of recent partnering and M&A activity - see it now - Scorecard Index.
Updated monthly - we will be updating our Scorecard Index - tracking partnering and M&A deals announced every month.
In additon, we track the leading deals by value in the current year, plus a compendium of top deals by value since 2000 - view details at Scorecard.
Latest update! Bigpharma partnering activity 2006 to present - view details here
Best practice articles
Barcelona plays host to BIO-Europe Spring 2010
The 4th edition of BIO-Europe Spring® will attract leaders from the international biotech industry to Barcelona, Spain on March 8-10, where local host BioRegion of Catalonia (Biocat) promises to surprise attendees with opportunities for projects, products and investments more
Royalty Rates For Technology Transactions
An interesting study was carried out between 1990 and 2007 which discovered that the most frequently negotiated royalty rate is 5% of net sales more
Big Pharma seeks to insulate itself from impact of ‘patent cliff’
As the pharmaceutical industry hurtles ever closer towards the ‘patent cliff’, Big Pharma* is busy implementing strategies to lessen the impact of the loss of patent protection on some of the industry’s biggest sellers on their collective bottom lines more
Tell Them Clearly What You’re Not Interested In!
One of the challenges prior to each partnering conference is the issue of other delegates asking you for a meeting to discuss an opportunity which you are not interested in more
Read all our partnering best practice articles.
New and updated reports
New report titles:
CurrentPartnering has published new titles:
Drug Delivery Partnering Agreements in Pharma, Biotech and Diagnostics
Provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds leading companies
- Comprehensive directory of drug delivery deals since 2003
- Drug delivery contract documents
- Drug delivery agreement terms
- Drug delivery agreement structure
- Top drug delivery deals by value
- Most active drug delivery dealmakers
- Access links to over 800 actual drug delivery contract agreements
More details and order
Partnering Agreements in Diagnostics
Providing detailed understanding and analysis of how and why companies enter diagnostic partnering deals, plus access to actual diagnostic agreements
- Comprehensive directory of diagnostic deals since 2003
- Diagnostic contract documents
- Diagnostic agreement terms
- Diagnostic agreement structure
- Top diagnostic deals by value
- Most active diagnostic dealmakers
More details and order
Oncology Partnering Agreements in Pharma, Biotech and Diagnostics
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies
- Comprehensive directory of oncology deals since 2003
- Oncology contract documents
- Oncology agreement terms
- Oncology agreement structure
- Top oncology deals by value
- Most active oncology dealmakers
More details and order
Option & Evaluation Agreements in Pharma and Biotech
The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies
More details and order
Royalty Financing Agreements in Pharma, Biotech and Diagnostics
The Royalty Financing Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.
More details and order
Revised and updated reports:
CurrentPartnering has revised and updated its most popular reports:
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition
The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies
More details and order
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 2nd edition
The Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. Revised and updated 2nd edition
More details and order
Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition
CurrentPartnering’s Practical Guide to Finding Partners in Pharma & Biotech provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity
More details and order
New from Datamonitor:
Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape
Since the financial meltdown, the relationship between Pharma and Biotech has been turned on its head. Previously, pharma companies had no choice but to license Biotech drugs at high prices in order to fill their sparse late stage pipelines
More details and order
Forthcoming events
Here are some of our suggested events for winter 2010:
BioBusiness 2010
London, UK - January 19-20, 2010 - more details
8th Annual BioPartnering North America 2010
Vancouver, B.C., Canada - January 24-26, 2010 - more details
14th Annual Drug Delivery Partnerships
Orlando, FL, USA - January 25-27, 2010 - more details
BIO-Windhover 2010/Pharmaceutical Strategic Outlook 2010
New York, USA - February 23-25, 2010 - more details
EuroPLX 42 Valletta
Portomaso/Valletta, Malta - March 1-2, 2010 - more details
BioEurope Spring 2010
Barcelona, Spain - March 8-10, 2010 - more details
Collaborations, Deals and Alliances
Philadelphia, PA, USA - April 11-14, 2010 - more details
MedTech Investing Europe 2010
Paris, France - April 29-30, 2010 - more details
BIO International Convention 2010
Chicago, IL, USA - May 3-6, 2010 - more details
Annual C21 Bioventures 2010
Napa, CA, USA - May 25-27, 2010 - more details
PharmaPartnering Live 2010
Online powered by ON24 - May 26-27, 2010 - more details
View our full events calendar
People on the move
The following people have been reported on the move during January 2010:
Zachary Zimmerman, Francesco Granata, Kerry Reinertsen, Jeffrey Paulsen, Art Ziegler, Tim Hanke to name just a few
read more about the latest people on the move
If you have news about a business development executive who is on the move - let us know
Partnering resources
Current Partnering maintains and regularly updates this list of useful resources for dealmakers across all industries.
The following topic areas are available - updated regularly:
- Partnering organizations
- Financing organizations
- Online Partnering
- Weblogs
- Mentoring/Networking
- Checklists
- Quotes
- Software Tools
- Library
- Journals
- Careers
- Training/education
- Other useful links
Missing something? Let us know and we will include all appropriate resources.
Contact us
Steve Poile, Editor
Web: http://www.CurrentPartnering.com
Mail: CurrentPartnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom
Tel: +44 7896 656732
Fax: +44 8703 305993
Email
Advertizing and sponsorship
CurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online.
or contact us to discuss your requirements.
About CurrentPartnering
CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers
- Reports
- Articles
- In the news
- Networks
- Scorecard
- Events
- On the move
- Careers
- Glossary
- Resources
- Advisers
|